Kia Sima Kheradmand, Gorski Marcin M, Giannakopoulos Stavros, Verrijzer C Peter
Department of Biochemistry, Center for Biomedical Genetics, Erasmus University Medical Center, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands.
Mol Cell Biol. 2008 May;28(10):3457-64. doi: 10.1128/MCB.02019-07. Epub 2008 Mar 10.
Stable silencing of the INK4b-ARF-INK4a tumor suppressor locus occurs in a variety of human cancers, including malignant rhabdoid tumors (MRTs). MRTs are extremely aggressive cancers caused by the loss of the hSNF5 subunit of the SWI/SNF chromatin-remodeling complex. We found previously that, in MRT cells, hSNF5 is required for p16(INK4a) induction, mitotic checkpoint activation, and cellular senescence. Here, we investigated how the balance between Polycomb group (PcG) silencing and SWI/SNF activation affects epigenetic control of the INK4b-ARF-INK4a locus in MRT cells. hSNF5 reexpression in MRT cells caused SWI/SNF recruitment and activation of p15(INK4b) and p16(INK4a), but not of p14(ARF). Gene activation by hSNF5 is strictly dependent on the SWI/SNF motor subunit BRG1. SWI/SNF mediates eviction of the PRC1 and PRC2 PcG silencers and extensive chromatin reprogramming. Concomitant with PcG complex removal, the mixed lineage leukemia 1 (MLL1) protein is recruited and active histone marks supplant repressive ones. Strikingly, loss of PcG complexes is accompanied by DNA methyltransferase DNMT3B dissociation and reduced DNA methylation. Thus, various chromatin states can be modulated by SWI/SNF action. Collectively, these findings emphasize the close interconnectivity and dynamics of diverse chromatin modifications in cancer and gene control.
INK4b-ARF-INK4a肿瘤抑制基因座的稳定沉默发生在多种人类癌症中,包括恶性横纹肌样瘤(MRT)。MRT是由SWI/SNF染色质重塑复合物的hSNF5亚基缺失引起的极具侵袭性的癌症。我们之前发现,在MRT细胞中,hSNF5是p16(INK4a)诱导、有丝分裂检查点激活和细胞衰老所必需的。在这里,我们研究了多梳蛋白组(PcG)沉默和SWI/SNF激活之间的平衡如何影响MRT细胞中INK4b-ARF-INK4a基因座的表观遗传控制。hSNF5在MRT细胞中的重新表达导致SWI/SNF的募集以及p15(INK4b)和p16(INK4a)的激活,但不包括p14(ARF)。hSNF5介导的基因激活严格依赖于SWI/SNF运动亚基BRG1。SWI/SNF介导PRC1和PRC2 PcG沉默因子的驱逐以及广泛的染色质重编程。伴随着PcG复合物的去除,混合谱系白血病1(MLL1)蛋白被募集,活性组蛋白标记取代了抑制性标记。引人注目的是,PcG复合物的缺失伴随着DNA甲基转移酶DNMT3B的解离和DNA甲基化的减少。因此,各种染色质状态可以通过SWI/SNF的作用进行调节。总的来说,这些发现强调了癌症和基因控制中不同染色质修饰之间的紧密相互联系和动态变化。